Keyword: Novo Nordisk

Markets & Companies

Opportunities for Western CDMOs in China

29.11.2018 - As part of its journey toward being a full-fledged advanced economy, the role and presence of China within the pharmaceutical industry has rapidly evolved throughout the recent...

News

Ossianix and Novo Nordisk link on BBB Research

13.09.2018 - Ossianix, a privately held US pharmaceutical research firm based in Philadelphia, Pennsylvania, has entered a research collaboration and option agreement with Danish drugmaker Novo...

News

Novo Nordisk Buys Ziylo Spin-out

27.08.2018 - Danish pharma Novo Nordisk is boosting its efforts to develop the world’s first glucose responsive insulin and transform the treatment of diabetes following its purchase of Ziylo...

News

Novo Nordisk and Kallyope in Gut-Brain Pact

25.06.2018 - Danish drugmaker Novo Nordisk is collaborating with Kallyope, a US biotech focused on the gut-brain axis, to discover novel peptide therapeutics for obesity and diabetes. Kallyope...

News

Novo Nordisk said to plan Major Layoffs

11.06.2018 - Drugmaker Novo Nordisk plans to cut as many as 3,000 jobs and may reduce its financial guidance, according to a report in the Danish financial newspaper Borsen. The paper, citing...

News

Novo Nordisk Gets EU Nod for Diabetes Drug

13.02.2018 - Danish drugmaker Novo Nordisk has been granted marketing approval by the European Commission for its Ozempic (semaglutide) diabetes treatment. The once-weekly drug, a glucagon-like...

News

Kare Schultz Named CEO of Teva

13.09.2017 - After a protracted search, Israeli generics giant Teva has appointed a new president and chief executive officer. Kåre Schultz will take over from interim CEO Yitzhak Peterburg at...

News

Novo Nordisk Settles $58.7 Million in US Fines

08.09.2017 - Danish pharmaceutical producer Novo Nordisk’s US subsidiary is paying nearly $58.7 million to resolve claims that, among other things, it misrepresented a warning by the US Food...